Document Detail

Quantitative relationship between coronary artery calcium score and hyperemic myocardial blood flow as assessed by hybrid 15O-water PET/CT imaging in patients evaluated for coronary artery disease.
Jump to Full Text
MedLine Citation:
PMID:  22076826     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: The incremental value of CAC over traditional risk factors to predict coronary vasodilator dysfunction and inherent myocardial blood flow (MBF) impairment is only scarcely documented (MBF). The aim of this study was therefore to evaluate the relationship between CAC content, hyperemic MBF, and coronary flow reserve (CFR) in patients undergoing hybrid (15)O-water PET/CT imaging.
METHODS: We evaluated 173 (mean age 56 ± 10, 78 men) patients with a low to intermediate likelihood for coronary artery disease (CAD), without a documented history of CAD, undergoing vasodilator stress (15)O-water PET/CT and CAC scoring. Obstructive coronary artery disease was excluded by means of invasive (n = 44) or CT-based coronary angiography (n = 129).
RESULTS: 91 of 173 patients (52%) had a CAC score of zero. Of those with CAC, the CAC score was 0.1-99.9, 100-399.9, and ≥400 in 31%, 12%, and 5% of patients, respectively. Global CAC score showed significant inverse correlation with hyperemic MBF (r = -0.32, P < .001). With increasing CAC score, there was a decline in hyperemic MBF on a per-patient basis [3.70, 3.30, 2.68, and 2.53 mL · min(-1) · g(-1), with total CAC score of 0, 0.1-99.9, 100-399.9, and ≥400, respectively (P < .001)]. CFR showed a stepwise decline with increasing levels of CAC (3.70, 3.32, 2.94, and 2.93, P < .05). Multivariate analysis, including age, BMI, and CAD risk factors, revealed that only age, male gender, BMI, and hypercholesterolemia were associated with reduced stress perfusion. Furthermore, only diabetes and age were independently associated with CFR.
CONCLUSION: In patients without significant obstructive CAD, a greater CAC burden is associated with a decreased hyperemic MBF and CFR. However, this association disappeared after adjustment for traditional CAD risk factors. These results suggest that CAC does not add incremental value regarding hyperemic MBF and CFR over established CAD risk factors in patients without obstructive CAD.
Authors:
Ibrahim Danad; Pieter G Raijmakers; Yolande E Appelman; Hendrik J Harms; Stefan de Haan; Koen M Marques; Cornelis van Kuijk; Cornelis P Allaart; Otto S Hoekstra; Adriaan A Lammertsma; Mark Lubberink; Albert C van Rossum; Paul Knaapen
Related Documents :
15084546 - Poor concordance of commonly used echocardiographic measures of left ventricular diasto...
19713716 - Atrioventricular valve annulus velocity and acceleration during global hypoxia in newbo...
3565246 - Alterations in myocardial systolic and diastolic function in patients with active syste...
19340476 - Left ventricular systolic function of newborns with asphyxia evaluated by tissue dopple...
23040596 - Development of a method to risk stratify patients with heart failure for 30-day readmis...
2226506 - Polymorphonuclear leucocytes as potential source of free radicals in the ischaemic-repe...
Publication Detail:
Type:  Journal Article     Date:  2011-11-11
Journal Detail:
Title:  Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology     Volume:  19     ISSN:  1532-6551     ISO Abbreviation:  J Nucl Cardiol     Publication Date:  2012 Apr 
Date Detail:
Created Date:  2012-03-27     Completed Date:  2012-08-07     Revised Date:  2013-06-27    
Medline Journal Info:
Nlm Unique ID:  9423534     Medline TA:  J Nucl Cardiol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  256-64     Citation Subset:  IM    
Affiliation:
Department of Cardiology, VU University Medical Center, De Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Calcinosis / diagnosis*,  epidemiology*
Coronary Artery Disease / diagnosis*,  epidemiology*
Female
Humans
Hyperemia / diagnosis*,  epidemiology
Male
Middle Aged
Myocardial Perfusion Imaging / statistics & numerical data*
Netherlands / epidemiology
Oxygen Radioisotopes / diagnostic use
Positron-Emission Tomography / statistics & numerical data*
Prevalence
Reproducibility of Results
Risk Assessment
Risk Factors
Sensitivity and Specificity
Subtraction Technique
Tomography, X-Ray Computed / statistics & numerical data*
Water / diagnostic use
Chemical
Reg. No./Substance:
0/Oxygen Radioisotopes; 7732-18-5/Water
Comments/Corrections
Comment In:
J Nucl Cardiol. 2012 Apr;19(2):227-9   [PMID:  22290310 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Full Text
Journal Information
Journal ID (nlm-ta): J Nucl Cardiol
Journal ID (iso-abbrev): J Nucl Cardiol
ISSN: 1071-3581
ISSN: 1532-6551
Publisher: Springer-Verlag, New York
Article Information
Download PDF
© The Author(s) 2011
Received Day: 8 Month: 7 Year: 2011
Accepted Day: 22 Month: 10 Year: 2011
Electronic publication date: Day: 11 Month: 11 Year: 2011
pmc-release publication date: Day: 11 Month: 11 Year: 2011
Print publication date: Month: 4 Year: 2012
Volume: 19 Issue: 2
First Page: 256 Last Page: 264
ID: 3313028
PubMed Id: 22076826
Publisher Id: 9476
DOI: 10.1007/s12350-011-9476-7

Quantitative relationship between coronary artery calcium score and hyperemic myocardial blood flow as assessed by hybrid 15O-water PET/CT imaging in patients evaluated for coronary artery disease
Ibrahim Danad, MD1
Pieter G. Raijmakers, MD, PhD2
Yolande E. Appelman, MD, PhD1
Hendrik J. Harms, MSc2
Stefan de Haan, MD1
Koen M. Marques, MD, PhD1
Cornelis van Kuijk, MD, PhD3
Cornelis P. Allaart, MD, PhD1
Otto S. Hoekstra, MD, PhD2
Adriaan A. Lammertsma, PhD2
Mark Lubberink, PhD2
Albert C. van Rossum, MD, PhD1
Paul Knaapen, MD, PhD1 Address: + 31 20 4442244 + 31 20 4442446 p.knaapen@vumc.nl
1Department of Cardiology, VU University Medical Center, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands
2Department of Nuclear Medicine & PET Research, VU University Medical Center, Amsterdam, The Netherlands
3Department of Radiology, VU University Medical Center, Amsterdam, The Netherlands

Introduction

The presence of coronary artery calcium (CAC) is a marker of vascular injury and related to the extent of coronary atherosclerotic burden.1-3 Computed tomography (CT) is a routinely used and a well-validated non-invasive imaging modality for the assessment and quantification of coronary atherosclerosis as represented by CAC.3 Previous studies have shown a positive relation between CAC and the anatomic severity of coronary artery disease (CAD),2,4,5 even after correction for traditional risk factors.6-8 These risk factors in turn are known to affect myocardial perfusion, even in the absence of CAD.9 The incremental value of CAC over traditional risk factors to predict coronary vasodilator dysfunction and inherent myocardial blood flow (MBF) impairment is only scarcely documented.10-14 Moreover, the results from these studies are conflicting and hampered by small sample size, varying patients populations, and the use of suboptimal imaging techniques to quantify MBF.

This study aimed to determine the relationship between CAC score and MBF in a large clinical cohort of symptomatic subjects suspected of and with risk factors for CAD undergoing hybrid 15O-water PET/CT imaging, in whom obstructive CAD was excluded by means of invasive (ICA) or CT-based coronary angiography (CTCA). In addition, the additive impact of CAC score on MBF over gender, age, and conventional CAD risk factors was explored.


Methods
Patient Population

Data were obtained from a cohort of 249 patients being clinically evaluated for CAD and therefore referred for CTCA, CAC-scoring, and PET MBF measurements on a hybrid PET/CT scanner (Gemini TF 64, Philips Healthcare, Best, The Netherlands). Patients were referred because of stable (atypical) angina or an elevated risk for CAD (presence of two or more risk factors) in the absence of symptoms. Hypertension was defined as a blood pressure ≥140/90 mm Hg or the use of anti-hypertensive medication. Hypercholesterolemia was defined as total cholesterol level ≥5 mmol/L or treatment with cholesterol lowering medication. Patients were classified as having diabetes if they were receiving treatment with oral hypoglycemic drugs or insulin. A positive family history of CAD was defined by the presence of CAD in first-degree relatives younger than 55 years in men or 65 years in women. Obstructive CAD was considered to have been ruled out when either one of the following criteria had been met: (1) absence of a luminal stenosis of more than 50% at ICA (N.B. Referral for ICA was left to the discretion of the treating physician); (2) when ICA was not available, a CTCA of sufficient quality enabling adequate grading of all major coronary segments which did not display a stenosis of more than 50%. Exclusion criteria were atrial fibrillation, second- or third-degree atrioventricular block, symptomatic asthma, pregnancy, or a documented history of CAD. A history of CAD was defined as a prior percutaneous coronary intervention, coronary artery bypass graft surgery, or a previous myocardial infarction. A total of 173 out of the 249 evaluated patients met these criteria and are described in the current study (78 men: mean age 55, range 33-79 years; and 95 women: mean age 57, range 31-84 years). Electrocardiography did not show signs of a previous myocardial infarction, and echocardiography showed a normal left ventricular function without wall motion abnormalities in all patients. CAD pre-test likelihood was determined according to the Diamond and Forrester criteria,15 using percent cutoffs of <13.4%, >87.2%, and in between for low, high, and intermediate pre-test likelihood, respectively.

PET Imaging

Patients were instructed to refrain from intake of products containing caffeine or xanthine 24 hours prior to the scan. After a scout CT for patient positioning and 2 minutes after the start of intravenous adenosine infusion 140 μg · kg−1 · min−1, 370 MBq of 15O-water was injected as a 5 mL (0.8 mL · s−1) bolus, followed immediately by a 35-mL saline flush (2 mL · s−1). A 6-minute emission scan was started simultaneously with the administration of 15O-water. This dynamic scan sequence was followed immediately by a respiration-averaged low dose CT scan (LD-CT) to correct for attenuation (55 mAs; rotation time, 1.5 s; pitch, 0.825; collimation, 16 × 0.625; acquiring 20 cm in 37 s) during normal breathing.16 Adenosine infusion was terminated after the LD-CT. After an interval of 10 minutes to allow for decay of radioactivity and washout of adenosine, an identical PET sequence was performed during resting conditions. Images were reconstructed using the 3D row action maximum likelihood algorithm into 22 frames (1 × 10, 8 × 5, 4 × 10, 2 × 15, 3 × 20, 2 × 30, and 2 × 60 seconds), applying all appropriate corrections. Parametric MBF images were generated and quantitative analysis was performed using in-house developed software, Cardiac VUer.17,18 MBF was expressed in mL · min−1 · g−1 of perfusable tissue and analyzed according to the 17-segment model of the American Heart Association.19 In addition to calculating the MBF for the left ventricle as a whole, MBF was calculated for each of three vascular territories (LAD, left anterior descending; LCx, left circumflex; and RCA, right coronary artery).

CT Imaging

Patients with a stable heart rate below 65 bpm (either spontaneous or after administration of oral and/or intravenous metoprolol) underwent a CT scan for calcium scoring and/or CTCA. A standard scanning protocol was applied, with 64 × 0.625-mm section collimation, 420-ms gantry rotation time, 120-kV tube voltage, and a tube current of 800 to 1000 mA (for CTCA), and 100 to 120 mA (for calcium scoring) depending on patients body size. All scans were performed with electrocardiogram-gated dose modulation to decrease the radiation dose. Calcium scoring was obtained during a single breath hold and coronary calcification was defined as a plaque with an area of 1.03 mm2 and a density ≥130 HU. The CAC score was calculated according to the method described by Agatston.20 After calcium scoring a CTCA was performed, whereby a bolus of 100-mL iodinated contrast agent was injected intravenously (5 mL · s−1) followed by a 50 mL NaCl 0.9% flush. All CT-scans were analyzed with a 3-dimensional workstation (Brilliance, Philips Medical Systems, Best, The Netherlands) by an experienced radiologist and cardiologist who were blinded to the PET-results. The coronary tree was evaluated according to a 16-segment coronary artery model modified from the American Heart Association.21

Invasive Coronary Angiography

ICA was performed according to standard clinical protocols. The coronary tree was divided to a 16-segment coronary artery model modified from the American Heart Association.21 Significant CAD was ruled out when no stenosis was present or the diameter stenosis was visually scored ≤50%. All images were interpreted by at least two experienced interventional cardiologists.

Data Interpretation

CAC scores were calculated separately for the LAD (including the left main coronary artery), LCX artery, and RCA and then summed to provide a total CAC score. Coronary flow reserve (CFR) was defined as the ratio between hyperemic and baseline MBF. Coronary vascular resistance (mm Hg · mL · min−1 · g−1) during hyperemia was calculated by dividing mean arterial pressure (MAP) by hyperemic MBF.22 Furthermore, to study heterogeneity in MBF, the coefficient of variation (COV) was calculated on a per patient basis as the ratio of the standard deviation of the 17 myocardial segments and mean hyperemic MBF for that patient. Finally, to explore a potential perfusion decline along the course of the coronary artery from proximal to distal segments, the longitudinal perfusion gradient was calculated according to the method previously described by Hernandez-Pampaloni et al23 and initially proposed by Gould et al.24

Statistical Analysis

Continuous variables are presented as mean values ± SD, whereas categorical variables are expressed as actual numbers. For most analyses, we categorized CAC into 4 groups (0, 0.01-99.9, 100-399.9, and ≥400) to accommodate the fact that 52 % of the studied subjects had a CAC score of 0. The ln (CAC score + 1) transformation better normalized CAC distribution. Continuous variables between males and females were compared using the paired or unpaired two-sided Student’s t test, as appropriate. Comparison of differences in perfusion parameters across increasing levels of CAC score were performed using one-way analysis of variance (ANOVA) with Bonferroni’s correction for multiple pair-wise comparisons for localizing the source of the difference. Evaluation of relationships between variables was performed using Spearman’s rank correlation analysis. Univariable linear regression analyses were performed to examine the relationship between cardiac risk factors, age, gender, ln(CAC + 1) score and change in hyperemic MBF and CFR. In addition, predictors associated with hyperemic MBF and CFR, based on evidence from the literature,9 were included simultaneously in a multiple linear regression model using backward elimination. A P value ≤.05 (two-sided) was considered statistically significant. All statistical analysis was performed using SPSS software package (SPSS 15.0, Chicago, IL).


Results

Significant CAD was considered to be ruled out by ICA (44) and CTCA (129) in all patients (n = 173). Patient characteristics are shown in Table 1. The 173 subjects included had a global baseline MBF of 1.05 ± 0.34 mL · min−1 · g−1. During adenosine-induced hyperemia, MBF increased significantly to 3.40 ± 1.19 mL · min−1 · g−1 (P < .001). Coronary flow reserve (CFR) averaged 3.45 ± 1.32. The median CAC score in this cohort of symptomatic patients was 0 (interquartile range 0-31). Ninety-one of hundred and seventy-three patients (52%) had a CAC score of zero. Of those with CAC, the CAC score was 0.1-99.9, 100-399.9, and ≥ or =400 in 31%, 12%, and 5% of patients, respectively.

Hemodynamics

Table 2 summarizes the hemodynamic characteristics. During adenosine-induced hyperemia, heart rate, systolic blood pressure, and rate-pressure product increased significantly compared to baseline, whereas no significant changes occurred in diastolic blood pressure.

Per Patient Analysis

Stratification of patients into four groups based on their CAC scores (0, 0.01-99.9, 100-399.9, and ≥400) resulted in a comparable global baseline MBF among the four CAC groups, whereas hyperemic MBF (3.70, 3.30, 2.68, and 2.53 mL · min−1 · g−1) and CFR (3.70, 3.32, 2.94, and 2.93) gradually decreased with increasing CAC levels (Figure 1A, B). The COV, as a marker of heterogeneity in MBF, was comparable across all CAC score groups during both resting (P = .27) and stress conditions (P = .78) (Figure 2A). Furthermore, comparison of hyperemic MBF in the base-to-apex direction demonstrated no longitudinal perfusion gradient with increasing CAC scores (P = .67, Figure 2B). Minimal coronary vascular resistance (CVR) displayed a significant stepwise increase (P < .001) with increasing total CAC score (Figure 3A). Spearman’s rank correlations of baseline MBF, hyperemic MBF, CFR, minimal CVR, and COV of hyperemic MBF with ln (CAC + 1) score were −0.08 (P = .27), −0.32 (P< .001), −0.21 (P < .01), 0.33 (P < .001), and −0.05 (P = .54), respectively.

Per Vessel Analysis

In 173 patients, a total of 519 vascular territories were analyzed. The correlation between per-vessel ln (CAC + 1), hyperemic MBF (r = −0.31, P < .001), CFR (r = −0.22, P < .001), and minimal CVR (r = 0.33, P < .001) was modest but statistically significant. Furthermore, when grouped according to per-vessel CAC score, baseline MBF was comparable across increasing levels of CAC score (P = .18). In addition, mean hyperemic MBF (3.62, 2.97, 2.66, and 2.35 mL · min−1 · g−1), CFR (3.65, 3.09, 3.15, and 2.36) progressively declined across increasing CAC levels (P < .001) (Figure 1C, D). Minimal CVR showed a stepwise increase across increasing per-vessel CAC levels (24, 30, 30, and 34 mm Hg · mL · min−1 · g−1, respectively, P < .001) (Figure 3B). In addition, hyperemic MBF and CFR decreased with increasing number of coronary vessels containing atherosclerosis (Figure 4).

Predictors of Hyperemic MBF and CFR

Univariable regression analyses demonstrated that age (P < .01), male gender (P < .001), BMI (P < .01), diabetes (P = .04), hypercholesterolemia (P = .04), and ln(CAC + 1) score (P < .001) displayed an inverse relationship with hyperemic MBF. Furthermore, multivariable linear regression analyses were performed with predictors which were selected based on evidence from the literature on their association with an impaired hyperemic MBF or CFR.9 When these predictors, including ln(CAC + 1) score, were put simultaneously into a multivariable regression model only age, male gender, BMI, and hypercholesterolemia were identified to have an independently negative impact on hyperemic MBF (Table 3a). In addition, univariable and multivariable regression analyses were performed to identify predictors of CFR. Univariable analyses showed that age (P < .01), BMI (P = .03), diabetes (P < .01), hypertension (P = .04), and total ln(CAC + 1) (P < .01) were associated with a negative impact on CFR. Multivariable regression analyses demonstrated that only age and diabetes were independently correlated with a diminished CFR (Table 3b).


Discussion

The current study was conducted to explore the quantitative relationship between CAC and coronary vasodilator response in patients who were being evaluated for CAD by hybrid 15O-water PET/CT. In symptomatic patients with multiple risk factors and non-obstructive CAD, CAC score does not add incremental information over age, gender, and traditional risk factors to predict impairment of hyperemic MBF and CFR. Of interest, CAC was also not related to hyperemic perfusion heterogeneity or the longitudinal perfusion gradient from base to apex.

In line with the majority of previous studies, resting MBF was not related to the extent of coronary calcification.10-13 This observation is not surprising as resting MBF is modulated in response to myocardial metabolic demand and remains preserved till the point of a subtotal coronary stenosis.25,26 Schindler et al,14 however, have documented an inverse relation between CAC and resting MBF in a cohort of diabetic patients. These results may be explained by alterations in the hormonal milieu and insulin levels which are known to affect resting MBF in the more advanced stages or diabetes with coronary injury.27

The negative correlation between the extent of coronary calcium and hyperemic MBF and flow reserve is in concordance with prior studies in asymptomatic controls, patients suspected of CAD, and diabetics.10,11,28 Only studies including small number of patients or employing qualitative flow measurements instead of absolute quantitative MBF measurements have not been able to reproduce the relation between vasodilator function and CAC.12,13 Multivariate analysis revealed that only age, male gender, BMI, and hypercholesterolemia were associated with reduced stress perfusion. Of interest, CAC score was not an independent predictor of a diminished hyperemic MBF. This is consistent with previous work showing that CAC score has little incremental value in predicting a diminished vasodilator response.10,11 In contrast to the current data, in these previous studies significant CAD was not excluded and could therefore have contributed to the observed independent (weak) relationship between CAC and impaired MBF. Thus, although CAC is a strong predictor for future cardiovascular events and reflects total coronary atherosclerotic burden, the current results implicate that CAC score in symptomatic patients with multiple risk factors and no obstructive epicardial CAD, does not add incremental information regarding MBF over age, gender, BMI, and established coronary risk factors.

Another aspect of this study was to investigate the relation between heterogeneity of hyperemic MBF and CAC as some of the aforementioned studies have indicated such an relation.12,14 It was therefore hypothesized that increased levels of calcium may induce heterogeneity between coronary perfusion territories, on the one hand, and a longitudinal perfusion gradient from base to apex, on the other hand. Gould et al24 initially introduced the latter concept, where patients with non-significant CAD displayed a gradual longitudinal decline in hyperemic MBF from base to apex as measured with 13N-ammonia PET. These results were later confirmed by Hernandez-Pampaloni et al23 in asymptomatic patients with an increased risk profile for CAD. Invasive measurements have indeed demonstrated that a gradual hyperemic perfusion pressure gradient exists along the course of mild atherosclerotic coronary arteries.29 In the current study, however, there was no relationship between heterogeneity of hyperemic MBF and CAC. Moreover, no perfusion gradient was detected between the mid and the apical sections of the left ventricle with increasing CAC scores during adenosine-induced hyperemia. Several factors may have contributed to these observations. First, there might be differences between study populations. In the current study, 52% of patients displayed no coronary calcium and the lack of longitudinal perfusion gradient may well be explained by the lack of coronary artery disease in these patients in contrast to the cohort of patients described by Gould et al.24 Second, there are some methodological differences between studies. Previously documented base to apex gradients have been investigated using 13N-ammonia PET almost a decade ago. The scanner used in the current study, however, is characterized by a higher spatial resolution and hence less affected by partial volume effects. Moreover, the modeling procedure of 15O-water incorporates an intrinsic correction for partial volume effects. As wall thickness progressive declines from base to apex, part of the observed longitudinal perfusion gradient may be caused by partial volume effects. Third, the perfusion gradient was measured over only a relatively short longitudinal distance of the left ventricle, i.e., from the mid-ventricular to the apical portion in concordance with Hernandez-Pampaloni et al.23 This approach was chosen to avoid potential inclusion of the outflow tract of the left ventricle in the perfusion estimates. Nevertheless, when the longitudinal gradient was measured from the basal to the apical portion, no myocardial perfusion gradient was demonstrated in the current population (data not shown). In addition, the limited number of patients in the group having a CAC score ≥ 400 could have introduced bias. Further studies in larger populations are warranted to assess the effect of CAC on MBF heterogeneity.

Study Limitations

Some limitations of our study that may affect the current findings must be acknowledged. Significant CAD was presumed to have been excluded by invasive or CT-based coronary angiography. The number of routinely performed invasive coronary angiographies in the current population was limited. Although CTCA is an excellent tool for ruling out significant CAD with a negative predictive value of 97% to 99%,30,31 some patients with hemodynamic significant CAD may have been included. Furthermore, the current data were obtained in predominantly symptomatic patients and therefore the results may not be extrapolated to, for example, asymptomatic subjects. Studies in asymptomatic subjects have displayed conflicting results and therefore larger studies are warranted to further investigate the relationship between CAC score and coronary vasodilator function in specific subpopulations. Finally, it must be emphasized that for subgroup analyses the studied patient population was too small to draw definite conclusions.


Conclusions

In patients with an intermediate pre-test likelihood of CAD and with multiple CAD risk factors there was a statistically significant inverse correlation between hyperemic MBF, CFR, and the extent of CAC. However, this association disappeared after adjusting for age, gender, BMI, and conventional risk factors. These results suggest that CAC score does not add incremental value regarding hyperemic MBF and CFR over established CAD risk factors in patients with an intermediate pre-test likelihood of CAD and no obstructive epicardial CAD. Therefore, coronary artery calcifications and vasodilator reactivity reflect different aspects of coronary atherosclerosis.


We thank Judith van Es, Robin Hemminga, Amina Elouahmani and Nasserah Sais for performing the scans and Kevin Takkenkamp and Henri Greuter for producing 15O-labeled water.

Conflict of interest

None.

Open Access

This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.


References
1.. Sangiorgi G,Rumberger JA,Severson A,et al. Arterial calcification and not lumen stenosis is highly correlated with atherosclerotic plaque burden in humans: A histologic study of 723 coronary artery segments using nondecalcifying methodologyJ Am Coll CardiolYear: 19983112613310.1016/S0735-1097(97)00443-99426030
2.. Rumberger JA,Schwartz RS,Simons DB,Sheedy PF III,Edwards WD,Fitzpatrick LA. Relation of coronary calcium determined by electron beam computed tomography and lumen narrowing determined by autopsyAm J CardiolYear: 1994731169117310.1016/0002-9149(94)90176-78203333
3.. Wexler L,Brundage B,Crouse J,et al. Coronary artery calcification: pathophysiology, epidemiology, imaging methods, and clinical implications. A statement for health professionals from the American Heart Association. Writing GroupCirculationYear: 199694117511928790070
4.. Rumberger JA,Sheedy PF,Breen JF,Schwartz RS. Electron beam computed tomographic coronary calcium score cutpoints and severity of associated angiographic lumen stenosisJ Am Coll CardiolYear: 1997291542154810.1016/S0735-1097(97)00093-49180117
5.. Haberl R,Becker A,Leber A,et al. Correlation of coronary calcification and angiographically documented stenoses in patients with suspected coronary artery disease: Results of 1, 764 patientsJ Am Coll CardiolYear: 20013745145710.1016/S0735-1097(00)01119-011216962
6.. Ho JS,Fitzgerald SJ,Stolfus LL,et al. Relation of a coronary artery calcium score higher than 400 to coronary stenoses detected using multidetector computed tomography and to traditional cardiovascular risk factorsAm J CardiolYear: 20081011444144710.1016/j.amjcard.2008.01.02218471456
7.. Schmermund A,Denktas AE,Rumberger JA,et al. Independent and incremental value of coronary artery calcium for predicting the extent of angiographic coronary artery disease: Comparison with cardiac risk factors and radionuclide perfusion imagingJ Am Coll CardiolYear: 19993477778610.1016/S0735-1097(99)00265-X10483960
8.. Guerci AD,Spadaro LA,Goodman KJ,et al. Comparison of electron beam computed tomography scanning and conventional risk factor assessment for the prediction of angiographic coronary artery diseaseJ Am Coll CardiolYear: 19983267367910.1016/S0735-1097(98)00299-X9741510
9.. Kaufmann PA,Camici PG. Myocardial blood flow measurement by PET: Technical aspects and clinical applicationsJ Nucl MedYear: 200546758815632037
10.. Curillova Z,Yaman BF,Dorbala S,et al. Quantitative relationship between coronary calcium content and coronary flow reserve as assessed by integrated PET/CT imagingEur J Nucl Med Mol ImagingYear: 2009361603161010.1007/s00259-009-1121-119387640
11.. Wang L,Jerosch-Herold M,Jacobs DR Jr,Shahar E,Detrano R,Folsom AR. Coronary artery calcification and myocardial perfusion in asymptomatic adults: The MESA (Multi-Ethnic Study of Atherosclerosis)J Am Coll CardiolYear: 2006481018102610.1016/j.jacc.2006.04.08916949496
12.. Wieneke H,Schmermund A,Ge J,et al. Increased heterogeneity of coronary perfusion in patients with early coronary atherosclerosisAm Heart JYear: 200114269169710.1067/mhj.2001.11676411579361
13.. Pirich C,Leber A,Knez A,et al. Relation of coronary vasoreactivity and coronary calcification in asymptomatic subjects with a family history of premature coronary artery diseaseEur J Nucl Med Mol ImagingYear: 20043166367010.1007/s00259-003-1426-414740179
14.. Schindler TH,Facta AD,Prior JO,et al. Structural alterations of the coronary arterial wall are associated with myocardial flow heterogeneity in type 2 diabetes mellitusEur J Nucl Med Mol ImagingYear: 20093621922910.1007/s00259-008-0885-z18704406
15.. Diamond GA,Forrester JS. Analysis of probability as an aid in the clinical diagnosis of coronary-artery diseaseN Engl J MedYear: 19793001350135810.1056/NEJM197906143002402440357
16.. Lubberink M,Harms HJ,Halbmeijer R,Haan S,Knaapen P,Lammertsma AA. Low-dose quantitative myocardial blood flow imaging using 15O-water and PET without attenuation correctionJ Nucl MedYear: 20105157558010.2967/jnumed.109.07074820237035
17.. Harms HJ,Knaapen P,Raijmakers PG,Lammertsma AA,Lubberink M. Cardiac Vuer: Software for semi-automatic generation of parametric myocardial blood flow images from a [15O]H2O PET-CT scanJ Nucl MedYear: 20105147710.2967/jnumed.109.06971620150272
18.. Harms HJ,Knaapen P,Haan S,Halbmeijer R,Lammertsma AA,Lubberink M. Automatic generation of absolute myocardial blood flow images using [(15)O]H (2)O and a clinical PET/CT scannerEur J Nucl Med Mol ImagingYear: 20113893093910.1007/s00259-011-1730-321271246
19.. Cerqueira MD,Weissman NJ,Dilsizian V,et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart AssociationCirculationYear: 200210553954210.1161/hc0402.10297511815441
20.. Agatston AS,Janowitz WR,Hildner FJ,Zusmer NR,Viamonte M Jr,Detrano R. Quantification of coronary artery calcium using ultrafast computed tomographyJ Am Coll CardiolYear: 19901582783210.1016/0735-1097(90)90282-T2407762
21.. Austen WG,Edwards JE,Frye RL,et al. A reporting system on patients evaluated for coronary artery disease. Report of the Ad Hoc Committee for Grading of Coronary Artery Disease, Council on Cardiovascular Surgery, American Heart AssociationCirculationYear: 1975515401116248
22.. Knaapen P,Camici PG,Marques KM,et al. Coronary microvascular resistance: Methods for its quantification in humansBasic Res CardiolYear: 200910448549810.1007/s00395-009-0037-z19468781
23.. Hernandez-Pampaloni M,Keng FY,Kudo T,Sayre JS,Schelbert HR. Abnormal longitudinal, base-to-apex myocardial perfusion gradient by quantitative blood flow measurements in patients with coronary risk factorsCirculationYear: 200110452753210.1161/hc3001.09350311479248
24.. Gould KL,Nakagawa Y,Nakagawa K,et al. Frequency and clinical implications of fluid dynamically significant diffuse coronary artery disease manifest as graded, longitudinal, base-to-apex myocardial perfusion abnormalities by noninvasive positron emission tomographyCirculationYear: 20001011931193910779459
25.. Carli M,Czernin J,Hoh CK,et al. Relation among stenosis severity, myocardial blood flow, and flow reserve in patients with coronary artery diseaseCirculationYear: 199591194419517895351
26.. Uren NG,Melin JA,Bruyne B,Wijns W,Baudhuin T,Camici PG. Relation between myocardial blood flow and the severity of coronary-artery stenosisN Engl J MedYear: 19943301782178810.1056/NEJM1994062333025038190154
27.. Sundell J,Knuuti J. Insulin and myocardial blood flowCardiovasc ResYear: 20035731231910.1016/S0008-6363(02)00718-612566104
28.. Schindler TH,Schelbert HR,Quercioli A,Dilsizian V. Cardiac PET imaging for the detection and monitoring of coronary artery disease and microvascular healthJACC Cardiovasc ImagingYear: 2010362364010.1016/j.jcmg.2010.04.00720541718
29.. Bruyne B,Hersbach F,Pijls NH,et al. Abnormal epicardial coronary resistance in patients with diffuse atherosclerosis but “Normal” coronary angiographyCirculationYear: 20011042401240610.1161/hc4501.09931611705815
30.. Henneman MM,Schuijf JD,Werkhoven JM,et al. Multi-slice computed tomography coronary angiography for ruling out suspected coronary artery disease: What is the prevalence of a normal study in a general clinical population?Eur Heart JYear: 2008292006201310.1093/eurheartj/ehn28418573865
31.. Kajander S,Joutsiniemi E,Saraste M,et al. Cardiac positron emission tomography/computed tomography imaging accurately detects anatomically and functionally significant coronary artery diseaseCirculationYear: 201012260361310.1161/CIRCULATIONAHA.109.91500920660808

Figures

[Figure ID: Fig1]
Figure 1 

Per-patient (A, B) and per-vessel analysis (C, D). Relationships between coronary artery calcium (CAC) and A, C myocardial blood flow (MBF), and B, D coronary flow reserve (CFR)



[Figure ID: Fig2]
Figure 2 

Relationships between coronary artery calcium (CAC) and A coefficient of variation (COV), and B longitudinal perfusion gradient (mid-ventricular to apical regions)



[Figure ID: Fig3]
Figure 3 

Per-patient analysis (A) and per-vessel analysis (B). Relationships between coronary artery calcium (CAC) and hyperemic coronary vascular resistance (CVR)



[Figure ID: Fig4]
Figure 4 

Relationship between number of vessels containing CAC and myocardial blood flow (MBF) (A), and B coronary flow reserve



Tables
[TableWrap ID: Tab1] Table 1 

Patient characteristics (n = 173)


Characteristics N (%) or mean ± SD
Age (years) 56 ± 10
Male gender 78 (45%)
BMI (kg · m−2) 27 ± 4
Diabetes 36 (21%)
Hypertension 75 (43%)
Hypercholesterolemia 53 (31%)
Smoking history 69 (40%)
Family history 84 (49%)
Reason for referral
 Typical angina pectoris 36 (21%)
 Atypical angina pectoris 59 (34%)
 Non-anginal chest pain 57 (33%)
 High risk, no chest discomfort 21 (12%)
Pre-test likelihood of CAD 0.37 ± 0.30

CAD, Coronary artery disease; BMI, body mass index.


[TableWrap ID: Tab2] Table 2 

Systemic hemodynamics at baseline and hyperemia


Parameter Mean value ± SD
Heart rate (bpm)
 Baseline 62 ± 10
 Hyperemia 81 ± 13*
Systolic blood pressure (mm Hg)
 Baseline 113 ± 19
 Hyperemia 115 ± 19*
Diastolic blood pressure (mm Hg)
 Baseline 60 ± 9
 Hyperemia 60 ± 9
Mean arterial pressure (mm Hg)
 Baseline 78 ± 11
 Hyperemia 78 ± 12
Rate-pressure product
 Baseline 7064 ± 2019
 Hyperemia 9445 ± 2407*

Bpm, Beats per minute.

P < .05 vs baseline.


[TableWrap ID: Tab3] Table 3 

Backward multiple linear regression analysis with hyperemic MBF (a) and CFR (b) as the dependent variables


Independent variable β P value
(a)
 Age −0.03 <.001
 Male gender −1.07 <.001
 BMI −0.07 <.001
 Hypercholesterolemia −0.36 .04
(b)
 Age −0.03 <.01
 Diabetes mellitus type II −0.51 .04

After forcing age, gender, BMI, diabetes type II, hypertension, smoking history, hypercholesterolemia, family history and ln(CAC + 1) into the model. Only variables that had a P ≤ 0.05 were considered in the final model. MBF, Myocardial blood flow; CFR, coronary flow reserve; BMI, body mass index.



Article Categories:
  • Original Article

Keywords: Keywords Coronary artery calcium, hyperemic myocardial blood flow, coronary risk factors.

Previous Document:  Resolution adapted finite element modeling of radio frequency interactions on conductive resonant st...
Next Document:  Relationship between paraglottic space invasion and cervical lymph node metastasis in patients under...